This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Allergic reactions
  • /
  • Position statement for the use of omalizumab in th...

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients.

Read time: 1 mins
Published:1st Jan 2016
Author: Godse K, Rajagopalan M, Girdhar M, Kandhari S, Shah B, Chhajed PN, et al.
Availability: Free full text
Ref.:Indian Dermatol Online J. 2016 Jan-Feb;7(1):6-11.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest